GSK-BTZ117352

Study Sponsor: GSK

Study Title

A Phase I, Open-Label, Single-Dose, Two-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Participants with Varying Degrees of Hepatic Impairment and in Matched Control Participants with Normal Hepatic Function

Medicine or Vaccine (generic name)

gepotidacin

Sponsor Identification Number

BTZ117352

Trial Registry Identification Number(#'s)

NCT03562117

Medical Condition

Infections, Bacterial

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=117352

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03562117

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

February 2021